Search

everythinglearnresearchcommunity

for

Search:↓

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

More research is needed to understand and treat morphea effectively.

Chemokine signaling is important for hair development.

RANKL causes lymph nodes to grow by making certain cells multiply.

Biomaterials can help reduce skin scarring and improve wound healing.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Certain inflammatory factors may increase or decrease the risk of developing PCOS.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Exogenous stem cells can effectively integrate into hair follicles, promoting hair growth.

3D culture helps maintain hair growth cells better than 2D culture and identifies key genes for potential hair loss treatments.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

Fat tissue under the skin affects hair growth and aging; reducing its inflammation may help treat hair loss.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Neutrophils are important for causing chronic itch in atopic dermatitis, and blocking the CXCR3 receptor may reduce this itch.

Perifollicular fibrosis hinders hair regrowth in androgenetic alopecia, and new treatments targeting fibrosis are needed.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.

Different γδ T cell types have unique roles in causing alopecia areata.

Alopecia areata involves specific gene changes and immune pathways, offering new treatment targets.

New treatments for hair loss show promise with advanced therapies and better targeting.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

CHI3L1 and CXCL5 proteins help promote hair growth.

Antibody treatments show promise for hair loss but need more research.

Mechanical tension worsens keloid scars by activating inflammation and fibrosis pathways.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

AP-2α and AP-2β proteins are essential for healthy adult skin and hair.